194 related articles for article (PubMed ID: 33235031)
21. Renal Denervation.
Hameed MA; Dasgupta I
Adv Exp Med Biol; 2017; 956():261-277. PubMed ID: 27815927
[TBL] [Abstract][Full Text] [Related]
22. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
[TBL] [Abstract][Full Text] [Related]
23. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
[TBL] [Abstract][Full Text] [Related]
24. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
Azizi M; Sharp ASP; Fisher NDL; Weber MA; Lobo MD; Daemen J; Lurz P; Mahfoud F; Schmieder RE; Basile J; Bloch MJ; Saxena M; Wang Y; Sanghvi K; Jenkins JS; Devireddy C; Rader F; Gosse P; Claude L; Augustin DA; McClure CK; Kirtane AJ;
Circulation; 2024 Mar; 149(10):747-759. PubMed ID: 37883784
[TBL] [Abstract][Full Text] [Related]
25. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
26. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Davies J; Basile J; Kirtane AJ; Wang Y; Lobo MD; Saxena M; Feyz L; Rader F; Lurz P; Sayer J; Sapoval M; Levy T; Sanghvi K; Abraham J; Sharp ASP; Fisher NDL; Bloch MJ; Reeve-Stoffer H; Coleman L; Mullin C; Mauri L;
Lancet; 2018 Jun; 391(10137):2335-2345. PubMed ID: 29803590
[TBL] [Abstract][Full Text] [Related]
27. Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.
Rabbia F; Testa E; Fulcheri C; Berra E; Di Monaco S; Covella M; Pappaccogli M; Monticone S; Rosiello R; Rossato D; Veglio F
High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):187-192. PubMed ID: 28374154
[TBL] [Abstract][Full Text] [Related]
28. The SPYRAL HTN Global Clinical Trial Program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.
Kandzari DE; Kario K; Mahfoud F; Cohen SA; Pilcher G; Pocock S; Townsend R; Weber MA; Böhm M
Am Heart J; 2016 Jan; 171(1):82-91. PubMed ID: 26699604
[TBL] [Abstract][Full Text] [Related]
29. Renal Denervation: Is It Ready for Prime Time?
Lauder L; Wolf MA; Scholz SS; Hohl M; Mahfoud F; Böhm M
Curr Cardiol Rep; 2019 Jul; 21(8):80. PubMed ID: 31278490
[TBL] [Abstract][Full Text] [Related]
30. Renal sympathetic denervation for resistant hypertension.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2013 May; 29(5):636-8. PubMed ID: 23541665
[TBL] [Abstract][Full Text] [Related]
31. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
[TBL] [Abstract][Full Text] [Related]
32. Renal denervation for uncontrolled hypertension: critical review of the evidence.
Chen C; Upadhyay A
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):114-122. PubMed ID: 27922849
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
Mahfoud F; Tunev S; Ruwart J; Schulz-Jander D; Cremers B; Linz D; Zeller T; Bhatt DL; Rocha-Singh K; Böhm M; Melder RJ
Circ Cardiovasc Interv; 2014 Dec; 7(6):813-20. PubMed ID: 25336466
[TBL] [Abstract][Full Text] [Related]
34. RADIANCE-HTN TRIO: how the saga of renal denervation revisits hypertension therapy.
Tsioufis KP; Dimitriadis K
Cardiovasc Res; 2021 Sep; 117(11):e141-e143. PubMed ID: 34562002
[No Abstract] [Full Text] [Related]
35. Will the SPYRAL-OFF MED pivotal trial switch our interest in renal denervation back on?
De Maria GL
Cardiovasc Res; 2020 Sep; 116(11):e140-e142. PubMed ID: 32845964
[No Abstract] [Full Text] [Related]
36. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
Böhm M; Kario K; Kandzari DE; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Konstantinidis D; Choi JW; East C; Lee DP; Ma A; Ewen S; Cohen DL; Wilensky R; Devireddy CM; Lea J; Schmid A; Weil J; Agdirlioglu T; Reedus D; Jefferson BK; Reyes D; D'Souza R; Sharp ASP; Sharif F; Fahy M; DeBruin V; Cohen SA; Brar S; Townsend RR;
Lancet; 2020 May; 395(10234):1444-1451. PubMed ID: 32234534
[TBL] [Abstract][Full Text] [Related]
38. Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future.
Silva JD; Costa M; Gersh BJ; Gonçalves L
J Am Soc Hypertens; 2016 Aug; 10(8):656-70. PubMed ID: 27319336
[TBL] [Abstract][Full Text] [Related]
39. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies.
Pappaccogli M; Covella M; Berra E; Fulcheri C; Di Monaco S; Perlo E; Burrello J; Monticone S; Rossato D; Rabbia F; Veglio F
High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):167-176. PubMed ID: 29752703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
